Indeed, increased methylation of CAHM was also found in the plasma DNA of 55% (40/73) of CRC patients, but not in 73 adenomas (4%) and 74 subjects without neoplasia (7%) (Pedersen et al., 2014). This evidence concerns the gene CAHM and neoplasm.